MRC1 and sebaceous gland neoplasm: Sebaceous neoplasms with dMMR most often demonstrated loss of MSH2/MSH6 on MMR-IHC across all studies (60–74%), with loss of MLH1/PMS2 (19–23%) as the second most common finding (Table 1).